TUTONE, Marco
 Distribuzione geografica
Continente #
NA - Nord America 5.614
EU - Europa 2.926
AS - Asia 740
SA - Sud America 24
AF - Africa 14
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.331
Nazione #
US - Stati Uniti d'America 5.590
IT - Italia 1.314
CN - Cina 526
FI - Finlandia 322
UA - Ucraina 294
IE - Irlanda 210
DE - Germania 200
GB - Regno Unito 158
BE - Belgio 83
IN - India 81
RU - Federazione Russa 75
FR - Francia 65
SE - Svezia 46
JP - Giappone 41
RO - Romania 36
NL - Olanda 34
ES - Italia 21
KR - Corea 15
MX - Messico 15
AT - Austria 14
BR - Brasile 13
CH - Svizzera 13
BG - Bulgaria 12
TR - Turchia 12
HK - Hong Kong 11
IR - Iran 11
AU - Australia 9
CA - Canada 8
CZ - Repubblica Ceca 8
GR - Grecia 8
TW - Taiwan 8
DZ - Algeria 7
PL - Polonia 7
UZ - Uzbekistan 7
LB - Libano 6
CL - Cile 5
JO - Giordania 4
PK - Pakistan 4
EU - Europa 3
IL - Israele 3
SG - Singapore 3
DK - Danimarca 2
EC - Ecuador 2
MY - Malesia 2
NG - Nigeria 2
UY - Uruguay 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
CI - Costa d'Avorio 1
GL - Groenlandia 1
HU - Ungheria 1
ID - Indonesia 1
KH - Cambogia 1
LK - Sri Lanka 1
MA - Marocco 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
TN - Tunisia 1
VN - Vietnam 1
Totale 9.331
Città #
Fairfield 751
Ashburn 514
Palermo 498
Chandler 463
Woodbridge 418
Houston 374
Ann Arbor 345
Wilmington 335
Seattle 287
Cambridge 259
Dublin 204
Medford 163
Jacksonville 157
Nanjing 116
Princeton 107
Brussels 74
Des Moines 71
Altamura 67
New York 62
Dearborn 55
San Diego 54
Lawrence 51
Hyderabad 46
Tulsa 46
Boardman 45
Beijing 44
Shenyang 43
Jinan 42
Ludwigshafen am Rhein 41
Hebei 38
Milan 37
Redwood City 31
Changsha 30
Nanchang 29
London 27
Tianjin 27
Jiaxing 24
Zhengzhou 24
Bremen 23
Napoli 21
Paris 19
Rome 19
Boydton 18
Amsterdam 17
Taizhou 16
Ningbo 15
Philadelphia 15
Catania 14
Cefalù 14
Seongnam 14
Taiyuan 13
Washington 13
Cagliari 12
Haikou 12
Kilburn 12
Los Angeles 12
Tokyo 12
Atlanta 11
Auburn Hills 11
Aversa 11
Helsinki 11
Messina 11
Edinburgh 10
Phoenix 10
Saint Petersburg 10
Sofia 10
Kumar 9
Norwalk 9
Trapani 9
Verona 9
Apeldoorn 8
Hangzhou 8
Barcelona 7
Chikmagalūr 7
Foggia 7
San Paolo di Civitate 7
Southwark 7
Baltimore 6
Bonn 6
Brno 6
Chicago 6
Frankfurt 6
Guangzhou 6
Kunming 6
Newcastle upon Tyne 6
Florence 5
Guiricema 5
Indiana 5
Lanzhou 5
Lappeenranta 5
Liège 5
Menlo Park 5
Moscow 5
San Giuliano Milanese 5
Termini Imerese 5
Trento 5
Villabate 5
Volturara Irpina 5
Adapazarı 4
Ali Mendjeli 4
Totale 6.593
Nome #
null 242
In vitro and in silico studies of polycondensed diazine systems as anti-parasitic agents 175
Indicaxanthin, a multi-target natural compound from Opuntia ficus-indica fruit: From its poly-pharmacological effects to biochemical mechanisms and molecular modelling studies 168
3D-QSAR Pharmacophore Modeling and in Silico Screening of new Bcl-xl Inhibitors 162
Trans-epithelial transport of the betalain pigments indicaxanthin and betanin across Caco-2 cell monolayers and influence of food matrix 160
Studies on a new potential dopaminergic agent: in vitro BBB permeability, in vivo behavioural effects and molecular docking evaluation 159
Theoretical Determination of the pK a Values of Betalamic Acid Related to the Free Radical Scavenger Capacity: Comparison Between Empirical and Quantum Chemical Methods 158
Phytochemical Indicaxanthin Inhibits Colon Cancer Cell Growth and Affects the DNA Methylation Status by Influencing Epigenetically Modifying Enzyme Expression and Activity 156
Uno studio comparativo in silico sui possibili target di Ataluren e analoghi farmaci promotori di readthrough di codoni di stop prematuri 156
Predicting Skin Permeability by Means of Computational Approaches: Reliability and Caveats in Pharmaceutical Studies 155
Inhibition of FTSJ1, a tryptophan tRNA-specific 2’-O-methyltransferase as possible mechanism to readthrough premature termination codons (UGAs) of the CFTR mRNA 152
A Multivariate Analysis of HIV-1 Protease Inhibitors and Resistance Induced by Mutation 152
Receptor-guided 3D-QSAR approach for the discovery of c-kit tyrosine kinase inhibitors 147
A multivariate analysis on non-nucleoside HIV-1 reverse transcriptase inhibitors and resistance induced by mutation 147
P015 Translational readthrough inducing drugs: a study of toxicity in mice models and in vitro safety validation of the specific readthrough process. 147
Molecular Dynamics studies on Mdm2 complexes: an analysis of the inhibitor influence 146
Exploring the readthrough of nonsense mutations by non-acidic Ataluren analogues selected by ligand-based virtual screening 144
A3 adenosine receptor: Homology modeling and 3D-QSAR studies 139
In-silico screening of new potential Bcl-2/Bcl-xl inhibitors as apoptosis modulators 138
Indicaxanthin from Opuntia ficus-indica Crosses the Blood−Brain Barrier and Modulates Neuronal Bioelectric Activity in Rat Hippocampus at Dietary-Consistent Amounts. 135
A multivariate analysis on HIV-1 protease inhibitors and resistance induced by mutation 131
Study of the role of “gatekeeper” mutations V654A and T670I of c-kit kinase in the interaction with inhibitors by means mixed molecular dynamics/docking approach 131
Does ligand symmetry play a role in the stabilization of DNA g-quadruplex host-guest complexes? 131
Molecular modelling and QSAR in the discovery of HIV-1 integrase inhibitors 129
DOCKING AND MULTIVARIATE METHODS TO EXPLORE HIV-1 DRUG-RESISTANCE: A COMPARATIVE ANALYSIS 129
Rescuing the CFTR protein function: Introducing 1,3,4-oxadiazoles as translational readthrough inducing drugs 129
A QSAR study investigating the potential anti-HIV-1 effect of some Acyclovir and Ganciclovir analogs 124
Targeting nonsense: Optimization of 1,2,4-oxadiazole trids to rescue cftr expression and functionality in cystic fibrosis cell model systems 121
Micelles of the chiral biocompatible surfactant (1R,2S)-dodecyl-(2-hydroxy-1-methyl-2-phenylethyl)dimethylammonium bromide (DMEB): Molecular dynamics and fragmentation patterns in the gas phase 119
Conf-VLKA: A structure-based revisitation of the Virtual Lock-and-key Approach 117
Recent advances on CDK inhibitors: An insight by means of in silico methods 111
Micelles, Rods, Liposomes, and Other Supramolecular Surfactant Aggregates: Computational Approaches 109
Design, synthesis and preliminary evaluation of dopamine-amino acid conjugates as potential D1 dopaminergic modulators 108
Molecular dynamics, dynamic site mapping, and highthroughput virtual screening on leptin and the Ob receptor as anti-obesity target 107
Derivati Ossadiazolici per il trattamento della fibrosi cistica: Readthrough di mutazioni nonsense 106
Strategies against nonsense: oxadiazoles as translational readthrough-inducing drugs (TRIDs) 106
A3 Adenosine Receptor: homology modeling and 3D-QSAR studies 105
IKK-beta inhibitors: An analysis of drug–receptor interaction by using Molecular Docking and Pharmacophore 3D-QSAR approaches 102
Design of new DNA-interactive agents by molecular docking and QSPR approach 99
Exploring the SARS-CoV-2 proteome in the search of potential inhibitors via structure-based pharmacophore modeling/docking approach 99
Molecular Modeling Approaches in the Discovery of New Drugs for Anti-Cancer Therapy: The Investigation of p53-MDM2 Interaction and its Inhibition by Small Molecules 96
Pharmacophore modelling as useful tool in the lead compounds identification and optimization 95
Pharmacophore-Based Design of New Chemical Scaffolds as Translational Readthrough-Inducing Drugs (TRIDs) 95
A Molecular Dynamics-Shared Pharmacophore Approach to Boost Early-Enrichment Virtual Screening: A Case Study on Peroxisome Proliferator-Activated Receptor α 94
Optimization of a new lead promoting the readthrough of the nonsense mutations for CFTR rescue in human CF cells 94
Virtual lock-and-key approach: The in silico revival of Fischer model by means of molecular descriptors 87
Bcl-2 come target di farmaci antitumorali modulatori dell'apoptosi 84
In Vitro Modulation of P-Glycoprotein Activity by Euphorbia intisy Essential Oil on Acute Myeloid Leukemia Cell Line HL-60R 83
Multivariate analysis in the identification of biological targets for designed molecular structures: The BIOTA protocol 82
Identification and validation of novel molecules obtained by integrated computational and experimental approaches for the read-through of PTCs in CF cells 81
Leptin and the ob-receptor as anti-obesity target: recent in silico advances in the comprehension of the protein-protein interaction and rational drug design of anti-obesity lead compounds 80
IN THE SEARCH OF LEPTIN AGONISTS AS ANTI-OBESITY DRUGS: PROTEIN/PROTEIN DOCKING, MOLECULAR DYNAMICS, AND VIRTUAL SCREENING 80
Molecular Modelling on Leptin and the Ob Receptor as anti-obesity target 79
Reverse screening on indicaxanthin from Opuntia ficus-indica as natural chemoactive and chemopreventive agent 79
Reverse Screening on Indicaxanthin from Opuntia ficus-indica as natural chemoactive and chemopreventive agent 79
QSAR and molecular docking techniques in the study of HIV-1 inhibitors 76
Rescuing CFTR Protein Function: 1,3,4-oxadiazoles versus 1,2,4-oxadiazoles as readthrough inducing drugs 76
CHA on CDK2: a way to identify the best pharmacophore model for the virtual screening of new inhibitors 76
Analisi Multivariata e Docking nello Studio degli Inibitori di HIV-1 Integrasi 74
DA-Phen, a new dopamine aminoacid conjugate: in vivo testing and molecular modeling as dopaminergic modulator 74
Translational Readthrough Inducing Drugs (TRIDs): a study of biodistribution evaluation in mice models 73
HIV-1 Protease Inhibitors and Resistance Induced by Mutation. Correlation between Multivariate Analysis and Molecular Docking. 73
TECNICHE DI MODELLISTICA MOLECOLARE NELLA PROGETTAZIONE DI INIBITORI DELL'ATTIVITÀ TRASCRIZIONALE DI HIF-1 72
Identification of a new molecule with readthrough activity to rescue CFTR protein function 72
METODI CHEMIOMETRICI NELLO STUDIO DEGLI INIBITORI DI HIV-1: TECNICHE STATITICHE MULTIVARIATE E MOLECULAR DOCKING 69
Studio del ruolo delle mutazioni “gatekeeper” V654A e T670I di c-kit kinase nell’interazione con inibitori attraverso un approccio misto Dinamica Molecolare/Docking 67
Molecular Modeling and Dynamics of the transcriptionfactor NF-kB complexed with IkB 65
A definitive pharmacophore modelling study on CDK2 ATP pocket binders: Tracing the path of new virtual high-throughput screenings 64
Studi di dinamica molecolare su Mdm2 legata a due differenti inibitori 63
Identification and validation of novel molecules obtained by integrated computational and experimental approaches for the readthrough of PTCs in CF cells 62
Comparing molecular dynamics-derived pharmacophore models with docking: A study on CDK-2 inhibitors 62
Computational methodologies in the discovery of inhibitors of HIV-1 61
Study on the mechanism of action of antitumor photochemotherapic agents by means of docking and QSPR analysis 61
The in silico fischer lock-and-key model: The combined use of molecular descriptors and docking poses for the repurposing of old drugs 61
Sulfonamide moiety as "molecular chimera" in the design of new drugs 60
MOLECULAR DYNAMICS - MULTIPLE RECEPTOR CONFORMATIONS APPROACH TO ENHANCE STRUCTURE-BASED VIRTUAL SCREENING ON PPAR-alpha RECEPTOR 59
Readthrough Inducing Drugs (TRIDs) in human fibroblasts harboring the c.5047 C>T (R1683*) nonsense mutation 58
Nonsense codons suppression. An acute toxicity study of three optimized TRIDs in murine model, safety and tolerability evaluation 57
MOLECULAR DYNAMICS AND DOCKING IN THE STUDY OF NEW INHIBITORS OF MDM2-p53 INTERACTION 57
Investigation on quantitative structure-activity relationships of 1,3,4-oxadiazole derivatives as potential telomerase inhibitors 57
Farmaci anti-HIV-1. Correlazioni tra analisi statistica multivariata e docking molecolare 55
Inside c-kit tyrosine kinase: molecular modeling and QSAR in the search of new inhibitors 55
THE DISCOVERY OF NEW HIF-1 INHIBITORS THROUGH MOLECULAR MODELING STUDIES 55
Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid Leukemia 55
The discovery of new inhibitors of HIF-1 transcriptional activity by virtual screening 53
In vitro and in silico studies of polycondensed diazine systems as anti-infective agents 53
Immunoproteasome and Non-Covalent Inhibition: Exploration by Advanced Molecular Dynamics and Docking Methods 52
Virtual lock and key approach: the revival of Fischer model 51
Pharmacophore modeling e screening in silico di nuovi inibitori della proteina antiapoptotica Bcl-xl 48
OXADIAZOLE DERIVATIVES FOR THE TREATMENT OF GENETIC DISEASES DUE TO NONSENSE MUTATIONS 48
Consensus modelling and molecular dynamics studies for the identification of novel telomerase inhibitors as anti-cancer agents 47
Synthesis, In Vitro and In Silico Analysis of New Oleanolic Acid and Lupeol Derivatives against Leukemia Cell Lines: Involvement of the NF-κB Pathway 47
Investigation on MMACHC-R161Q pathological mutant from cblC disease 46
TOWARD ENRICHED VHTS FOR CDK2 INHIBITORS: MOLECULAR DYNAMICS, PHARMACOPHORE MODELLING, AND DOCKING 46
Tecniche chemiometriche e di molecular modelling applicate all’analisi di Farmaci anti-HIV-1 44
A dynamic multiple receptor conformations (MD-MRC) approach to enhance early enrichment in virtual screening. A case study on PPAR-alpha 44
Evaluation of matrix effect on the GC/MS response of eighteen pesticides by multivariate approach 42
Exploring the non-covalent ligand-binding mechanism on immunoproteasome by enhanced Molecular Dynamics 42
Computational Approaches: Drug Discovery and Design in Medicinal Chemistry and Bioinformatics 41
Evaluation of the IKKβ Binding of Indicaxanthin by Induced-Fit Docking, Binding Pose Metadynamics, and Molecular Dynamics 41
Totale 9.353
Categoria #
all - tutte 33.662
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.662


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019514 0 0 0 0 0 0 0 0 29 119 183 183
2019/20202.254 252 98 147 196 227 312 220 142 202 119 253 86
2020/20211.434 67 119 38 129 190 76 105 110 151 185 116 148
2021/20221.316 90 236 30 34 21 61 58 86 150 160 94 296
2022/20231.868 202 220 49 239 208 273 108 140 178 49 116 86
2023/2024970 84 150 62 66 133 194 144 115 22 0 0 0
Totale 9.965